As artificial intelligence (AI) has started much influence on the production of many of the new medical technologies including diabetes, so what is bionic pancreas, its reliability, company of manufacturer, and price detail, or new published data in impact factor journal,
Dear Abdul,
I think the following recent papers will help you:
McAdams BH, Rizvi AA. An Overview of Insulin Pumps and Glucose Sensors for the Generalist. J Clin Med 2016;5(1).pii:E5. http://www.mdpi.com/2077-0383/5/1/5/htm
El-Khatib FH, Balliro C, Hillard MA, Magyar KL, Ekhlaspour L, Sinha M, Mondesir D, et al. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. Lancet 2017;389(10067):369-380. http://sites.bu.edu/bionicpancreas/files/2016/12/El-Khatib_etal_2016_Lancet.pdf
Russell SJ, Hillard MA, Balliro C, Magyar KL, Selagamsetty R, Sinha M, Grennan K, Mondesir D, Ehklaspour L, Zheng H, Damiano ER, El-Khatib FH. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. Lancet Diabetes Endocrinol 2016;4(3):233-43. http://sites.bu.edu/bionicpancreas/files/2016/02/Russell-Lancet-Diabetes.pdf
El-Khatib FH, Russell SJ, Magyar KL, Sinha M, McKeon K, Nathan DM, Damiano ER. Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. J Clin Endocrinol Metab 2014;99(5):1701-11. http://sites.bu.edu/bionicpancreas/files/2014/07/El-Khatib_etal_2014.pdf
Russell SJ, El-Khatib FH, Sinha M, Magyar KL, McKeon K, Goergen LG, Balliro C, Hillard MA, Nathan DM, Damiano ER. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 2014;371(4):313-325. http://www.nejm.org/doi/pdf/10.1056/NEJMoa1314474
Best wishes from Germany,
Martin
- Badges
- Science topic
- Similar topics
- Computer Science and Engineering
- Artificial Intelligence